Cargando…

Crohn’s Disease Localization Displays Different Predisposing Genetic Variants

BACKGROUND: Crohn’s disease (CD) is a pathologic condition with different clinical expressions that may reflect an interplay between genetics and environmental factors. Recently, it has been highlighted that three genetic markers, NOD2, MHC and MST1, were associated to distinct CD sites, supporting...

Descripción completa

Detalles Bibliográficos
Autores principales:	Palmieri, Orazio, Bossa, Fabrizio, Valvano, Maria Rosa, Corritore, Giuseppe, Latiano, Tiziana, Martino, Giuseppina, D’Incà, Renata, Cucchiara, Salvatore, Pastore, Maria, D’Altilia, Mario, Scimeca, Daniela, Biscaglia, Giuseppe, Andriulli, Angelo, Latiano, Anna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5215692/ https://www.ncbi.nlm.nih.gov/pubmed/28052082 http://dx.doi.org/10.1371/journal.pone.0168821

Ejemplares similares

Investigation of Multiple Susceptibility Loci for Inflammatory Bowel Disease in an Italian Cohort of Patients
por: Latiano, Anna, et al.
Publicado: (2011)

Functional Implications of MicroRNAs in Crohn’s Disease Revealed by Integrating MicroRNA and Messenger RNA Expression Profiling
por: Palmieri, Orazio, et al.
Publicado: (2017)

Addendum: Palmieri, O. et al. Functional Implications of MicroRNAs in Crohn’s Disease Revealed by Integrating MicroRNA and Messenger RNA Expression Profiling. Int. J. Mol. Sci. 2017, 18, 1580
por: Palmieri, Orazio, et al.
Publicado: (2017)

Associations between Genetic Polymorphisms in IL-33, IL1R1 and Risk for Inflammatory Bowel Disease
por: Latiano, Anna, et al.
Publicado: (2013)

Impact of the COVID-19 outbreak and the serum prevalence of SARS-CoV-2 antibodies in patients with inflammatory bowel disease treated with biologic drugs
por: Bossa, Fabrizio, et al.
Publicado: (2021)

Microbiome Analysis of Mucosal Ileoanal Pouch in Ulcerative Colitis Patients Revealed Impairment of the Pouches Immunometabolites
por: Palmieri, Orazio, et al.
Publicado: (2021)

Genome-wide Pathway Analysis Using Gene Expression Data of Colonic Mucosa in Patients with Inflammatory Bowel Disease
por: Palmieri, Orazio, et al.
Publicado: (2015)

New biologics in the management of Crohn’s disease: focus on certolizumab pegol
por: Colombo, Elisabetta, et al.
Publicado: (2009)

False-positive results of SARS-CoV-2 IgM/IgG antibody tests in sera stored before the 2020 pandemic in Italy
por: Latiano, Anna, et al.
Publicado: (2021)

Gene expression of muscular and neuronal pathways is cooperatively dysregulated in patients with idiopathic achalasia
por: Palmieri, Orazio, et al.
Publicado: (2016)

Mucosal Microbiota from Colorectal Cancer, Adenoma and Normal Epithelium Reveals the Imprint of Fusobacterium nucleatum in Cancerogenesis
por: Palmieri, Orazio, et al.
Publicado: (2023)

Circulating levels of cytokines, chemokines and growth factors in patients with achalasia
por: Panza, Anna, et al.
Publicado: (2021)

Droplet digital PCR quantification of miR-1290 as a circulating biomarker for pancreatic cancer
por: Tavano, Francesca, et al.
Publicado: (2018)

Transcriptome and Gene Fusion Analysis of Synchronous Lesions Reveals lncMRPS31P5 as a Novel Transcript Involved in Colorectal Cancer
por: Panza, Anna, et al.
Publicado: (2020)

Downexpression of miR-200c-3p Contributes to Achalasia Disease by Targeting the PRKG1 Gene
por: Micale, Lucia, et al.
Publicado: (2022)

Evaluation of inherited germline mutations in cancer susceptibility genes among pancreatic cancer patients: a single-center study
por: Tavano, Francesca, et al.
Publicado: (2023)

Adherence to Gluten-Free Diet Restores Alpha Diversity in Celiac People but the Microbiome Composition Is Different to Healthy People
por: Palmieri, Orazio, et al.
Publicado: (2022)

A PCR-based method for the diagnosis of Enterobius vermicularis in stool samples, specifically designed for clinical application
por: Ummarino, Aldo, et al.
Publicado: (2022)

Surgical management of female pelvic organ prolapse with and without urinary incontinence: A single center experience
por: Cormio, Luigi, et al.
Publicado: (2017)

Measuring disease activity in Crohn’s disease: what is currently available to the clinician
por: D’Incà, Renata, et al.
Publicado: (2014)

RS-SNP: a random-set method for genome-wide association studies
por: D'Addabbo, Annarita, et al.
Publicado: (2011)

Daily tadalafil for the chronic phase of stuttering priapism: a case report
por: Massenio, Paolo, et al.
Publicado: (2018)

Microbiota Manipulation by Probiotics Administration as Emerging Tool in Cancer Prevention and Therapy
por: Panebianco, Concetta, et al.
Publicado: (2020)

Multiple Autoimmune Skin Manifestations in a Patient with Crohn's Disease Treated with a Tumor Necrosis Factor-Alpha Blocker
por: Zattra, Edoardo, et al.
Publicado: (2015)

Combined Plaque Incision, Buccal Mucosa Grafting, and Additional Tunica Albuginea Plication for Peyronie’s Disease
por: Cormio, Luigi, et al.
Publicado: (2018)

Gut virome-colonising Orthohepadnavirus genus is associated with ulcerative colitis pathogenesis and induces intestinal inflammation in vivo
por: Massimino, Luca, et al.
Publicado: (2023)

Metabolomic profile in pancreatic cancer patients: a consensus-based approach to identify highly discriminating metabolites
por: Di Gangi, Iole Maria, et al.
Publicado: (2016)

Estimating antimalarial drugs consumption in Africa before the switch to artemisinin-based combination therapies (ACTs)
por: Kindermans, Jean-Marie, et al.
Publicado: (2007)

Branchio-Oto-Renal Syndrome (BOR) associated with focal glomerulosclerosis in a patient with a novel EYA1 splice site mutation
por: Gigante, Maddalena, et al.
Publicado: (2013)

Efficacy of teduglutide in a patient with Crohn’s disease and short bowel syndrome on enteral nutrition: let’s start to think out of the box
por: Barberio, Brigida, et al.
Publicado: (2019)

Preserving ejaculatory function in young patients with lower urinary tract symptoms: medium- to long-term follow-up of prostatic urethral lift at a single center
por: Annese, Pasquale, et al.
Publicado: (2021)

Good efficacy and safety of vedolizumab in Crohn’s disease and ulcerative colitis in a real-world scenario
por: Zingone, Fabiana, et al.
Publicado: (2020)

Immunolocalization of leptin and leptin receptor in colorectal mucosa of ulcerative colitis, Crohn’s disease and control subjects with no inflammatory bowel disease
por: Merigo, Flavia, et al.
Publicado: (2020)

High Levels of Prebiotic Resistant Starch in Diet Modulate a Specific Pattern of miRNAs Expression Profile Associated to a Better Overall Survival in Pancreatic Cancer
por: Trivieri, Nadia, et al.
Publicado: (2020)

Intestinal Permeability in Inflammatory Bowel Disease: Pathogenesis, Clinical Evaluation, and Therapy of Leaky Gut
por: Michielan, Andrea, et al.
Publicado: (2015)

Biomarkers in IBD: What to Utilize for the Diagnosis?
por: D’Incà, Renata, et al.
Publicado: (2023)

Intrahepatic Cholangiocarcinoma and Acute Intermittent Porphyria: A Case Report
por: Guida, Claudio Carmine, et al.
Publicado: (2023)

Exosomes: Tiny Clues for Mast Cell Communication
por: D’Incà, Federica, et al.
Publicado: (2015)

Prophylactic Treatment with Vedolizumab in the Prevention of Postoperative Recurrence (POR) in High-Risk Crohn’s Patients
por: Frieri, Giuseppe, et al.
Publicado: (2023)

Improving Gemcitabine Sensitivity in Pancreatic Cancer Cells by Restoring miRNA-217 Levels
por: Panebianco, Concetta, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_bnqknlo13nfcgg5bnb2ph0j64u